Our ambition is to transform care in haematology by pushing the boundaries of science and advancing innovation where it can have the greatest impact. At #ASH25, new data will spotlight next-generation modalities including T-cell engagers and cell therapies, and explore their potential to redefine care and reduce the treatment burden across a spectrum of diseases, including blood cancer, immune-mediated conditions and rare diseases. Learn more about our commitment to improving outcomes and elevat
0:14
Our ambition is to transform care in haematology by pushing the boundaries of science and advancing innovation where it can have the greatest impact. At #ASH25, new data will spotlight next-generation modalities including T-cell engagers and cell therapies, and explore their potential to redefine care and reduce the treatment burden across a spectrum of diseases, including blood cancer, immune-mediated conditions and rare diseases. Learn more about our commitment to improving outcomes and elevat
視聴回数: 2102 回7 か月前
FacebookAstraZeneca
さらに表示
静的サムネイルプレースホルダー